Conflict of interest "infects" BC drug review panel
Big Pharma helps OK drugs for sale in province.
by by Tom Sandborn, from TheTyee.ca – 4 October 2010
The door is now open to add pharmaceutical industry reps to the panel reviewing new drugs for use in BC. That builds in conflicts of interest, will raise risks to patients, and could cost taxpayers more, say the NDP health critic and a drug policy researcher.
But the Campbell government defends its controversial revamping of the drug review process, which used to be under the control of Therapeutics Initiative, an independent agency founded in 1994 at UBC. The time had come, a spokesperson told The Tyee, for a "more integrated" approach.
For the full story, see...
Posted: October 06, 2010
Public Values (PublicValues.ca) is a project of the Golden Lake Institute and the online publication StraightGoods.ca